Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/54507
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background 5′-deoxy-5′-methylthioadenosine (MTA) is an endogenous compound produced through the metabolism of polyamines. The therapeutic potential of MTA has been assayed mainly in liver diseases and, more recently, in animal models of multiple sclerosis. The aim of this study was to determine the neuroprotective effect of this molecule in vitro and to assess whether MTA can cross the blood brain barrier (BBB) in order to also analyze its potential neuroprotective efficacy in vivo. Methods Neuroprotection was assessed in vitro using models of excitotoxicity in primary neurons, mixed astrocyte-neuron and primary oligodendrocyte cultures. The capacity of MTA to cross the BBB was measured in an artificial membrane assay and using an in vitro cell model. Finally, in vivo tests were performed in models of hypoxic brain damage, Parkinson's disease and epilepsy. Results MTA displays a wide array of neuroprotective activities against different insults in vitro. While the data from the two complementary approaches adopted indicate that MTA is likely to cross the BBB, the in vivo data showed that MTA may provide therapeutic benefits in specific circumstances. Whereas MTA reduced the neuronal cell death in pilocarpine-induced status epilepticus and the size of the lesion in global but not focal ischemic brain damage, it was ineffective in preserving dopaminergic neurons of the substantia nigra in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine(MPTP)-mice model. However, in this model of Parkinson's disease the combined administration of MTA and an A2A adenosine receptor antagonist did produce significant neuroprotection in this brain region. Conclusion MTA may potentially offer therapeutic neuroprotection.
Matèries (anglès)
Citació
Citació
MORENO, Beatriz, LÓPEZ, Iciar, FERNÁNDEZ-DÍEZ, Begoña, GOTTLIEB, Miroslav, MATUTE, Carlos, SÁNCHEZ-GÓMEZ, María victoria, DOMERCQ, María, GIRALT COLL, Albert, ALBERCH I VIÉ, Jordi, COLLON, Kevin w., ZHANG, Helen, PARENT, Jack m., TEIXIDÓ TURÀ, Meritxell, GIRALT LLEDÓ, Ernest, CEÑA, Valentín, POSADAS, Inmaculada, MARTÍNEZ-PINILLA, Eva, VILLOSLADA, Pablo, FRANCO FERNÁNDEZ, Rafael. Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine. _PLoS One_. 2014. Vol. 9, núm. 3, pàgs. e90671. [consulta: 10 de gener de 2026]. ISSN: 1932-6203. [Disponible a: https://hdl.handle.net/2445/54507]